08:30 - 09:00

Program Registration

09:00 - 09:45

Welcome
Ela Bochenek, Seton Hall Law School

09:45 - 10:40

Ethics as a Foundation for Corporate Compliance Programs
Professor Timothy Glynn, Seton Hall Law School

10:40 - 11:00

Break

11:00 - 12:30

Global Anti-Corruption Enforcement
Wilson Ang, Norton Rose Fulbright (Singapore)
Paul Sumilas, Norton Rose Fulbright (Singapore)

12:30 - 13:30

Lunch

13:30 - 14:40

Being the Focus of a Government Investigation
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

14:40-15:00

Break

15:00-16:00

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations
Ken Chia, Baker & McKenzie, Wong & Leow (Singapore)

16:00-17:00

Interactive Team Exercise
Prof. Tim Glynn, Seton Hall Law School (New Jersey)
Ela Bochenek, Seton Hall Law School (New Jersey)

08:45

Sign-In

09:00-09:10

Key Concept Review & Corruption Quiz
Professor Timothy Glynn, Seton Hall Law School

09:10-10:25

Anti-Corruption Settlements
Eric Carlson, Covington & Burling (Shanghai)

10:25-10:50

Break

10:50-11:55

Focus on China
Eric Carlson, Covington & Burling (Shanghai)

11:55-13:00

Competition Law in the Healthcare Sector
Hwa Soo Chung, Kim & Chang (Seoul)
Yunjoh Lee, Kim & Chang (Seoul)

13:00-14:05

Lunch sponsored by Covington & Burling

14:05-15:05

Global and Regional Industry Codes (Pharma & Device)
Hwa-Soo Chung, Kim & Chang (Seoul)
Diva Duong, IQVIA (Paris)
Yunjoh Lee, Kim & Chang (Seoul)

15:05-15:25

Break

15:25-16:25

ASIA Transparency Trends & Challenges
Diva Duong, IQVIA (Paris)

16:25-17:45

Compliance Officers Panel Discussion
Masood Ahmed, Sanofi (Singapore)
Maija Burtmanis, Shire Biopharma (Japan)
Ronald Goon, Johnson & Johnson (Singapore)
Benjamin Kwak, Zimmer (Singapore)
Moderator: Professor Timothy Glynn, Seton Hall Law School (New Jersey)

17:45-19:30

Networking Reception for All Program Faculty & Attendees

08:45

Sign-In

09:00-10:00

Emerging Risk Areas
Maija Burtmanis,Shire Biopharma (Japan)

10:00-11:00

Interactive Case Study Session
Maija Burtmanis,Shire Biopharma (Japan)

11:00-11:20

Break

11:20-12:20

Assessing Third Party Risk
Masood Ahmed, Sanofi (Singapore)

12:20-13:20

Lunch sponsored by IQVIA and Polaris

13:20-14:30

Health Care in India
Dr. Milind Antani, Nishith Desai Associates (Mumbai)

14:30 - 14:50

Break

14:50-17:30

Interactive Session
Prof. Timothy Glynn, Seton Hall Law School (New Jersey)
Ela Bochenek, Seton Hall Law School (New Jersey)

08:45

Sign-In

09:00-10:00

Data Analytics
Lem Chin Kok, KPMG (Singapore)

10:00-11:00

Investigations Panel Discussion
Lem Chin Kok, KPMG (Singapore)
Giuseppe (“Pino”) Falbo, Shire (Dubai)

11:00-11:20

Break

11:20-12:05

Building & Growing a Compliance Team
Maru Quindimil, UCB (Shanghai)
Ela Bochenek, Seton Hall Law (New Jersey)

12:05-13:05

Lunch

13:05- 13:35

Interactive Session – Part 1 Teamwork: evaluate proposed activities, assess business & legal risk, and develop recommendations
Teamwork

13:35-15:35

Interactive Session - Part 2 Team Presentations & Classroom Discussion
Ronald Goon, Johnson & Johnson (Singapore)

15:35 - 16:00

Closing Remarks and Awarding of Program Certificates